Dr. Ferguson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-934-4011Fax+1 205-801-7551
Summary
- Dr. James Ferguson is an urologic oncologist in Birmingham, AL and is affiliated with University of Alabama Hospital and the Veterans Affairs hospital. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine in 2009, completed residency at UNC-Chapel Hill in 2016, and fellowship at MD Anderson Cancer Center in 2018. He specializes in urologic oncology.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2016 - 2018
- University of North Carolina HospitalsResidency, Urology, 2011 - 2016
- University of North Carolina HospitalsResidency, Surgery, 2011 - 2012
- Massachusetts General HospitalInternship, Internal Medicine, 2009 - 2010
- University of North Carolina at Chapel Hill School of MedicineClass of 2009
Certifications & Licensure
- AL State Medical License 2018 - 2024
- TX State Medical License 2016 - 2020
- NC State Medical License 2011 - 2016
- American Board of Urology Urology
Publications & Presentations
PubMed
- 11 citationsImpact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in t...Michael J. Metcalfe, James E. Ferguson, Roger Li, Lianchun Xiao, Charles C. Guo
European Urology Focus. 2017-07-13 - 20 citationsTherapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Alyncia D. Robinson, Joshua C. Anderson, Sumit Agarwal
Oncogene. 2020-03-30 - 18 citationsExpression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder CancerMarie-Lisa Eich, Maria Del Carmen Rodriguez Pena, Darshan S. Chandrashekar, Alcides Chaux, Sumit Agarwal
Translational Oncology. 2019-08-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: